Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Sarcoma 1Dermatologic 1CNS 1

Conditions

Gliosarcoma 3Glioblastoma 3Oligodendroglioma 2Glioma 2Central Nervous System Neoplasms 2Brain Neoplasms 2Astrocytoma 2Rhabdoid Tumor 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroblastoma 1Medulloblastoma 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Juvenile 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 59fludarabine phosphate 39Filgrastim 36Peripheral Blood Stem Cell Transplantation 34Cyclosporine 31Radiotherapy 30Busulfan 30Mycophenolic Acid 28Antilymphocyte Serum 27Whole-Body Irradiation 25Melphalan 22Etoposide 22Methylprednisolone 20Methotrexate 20Tacrolimus 16Cord Blood Stem Cell Transplantation 16Cytarabine 12Thiotepa 10Rituximab 8Vincristine 7Granulocyte Colony-Stimulating Factor 7sargramostim 6Carboplatin 6fludarabine 5aldesleukin 5Sirolimus 5Psychiatric Rehabilitation 5Prednisone 5Leucovorin 5Doxorubicin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Burkitt Lymphoma × Isotretinoin × Sarcoma × Clear all
NCT00217412 2014-06-17

Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia

National Cancer Institute (NCI)

Phase 1 Completed
60 enrolled
CNSLymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Medulloblastoma, Neuroblastoma, Recurrence, Lymphoma, Large B-Cell, Diffuse, Rhabdoid Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡